Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

MX-MAP Towards MXenes’ biomedical applications by high-dimensional immune MAPping

Coordinator
Universita Degli Studi Di Padova, Italy
Runs
1 November 2022 to 30 April 2027
Status
Running
EU funding
€1.4m
Total cost
—
Partners
16 organisations in 11 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101086184

What the project is doing

In the project's own words, from its summary on CORDIS.

The long-term goal of MX-MAP is to develop a functional pipeline for the immune characterization of new 2D nanomaterials of MXene family, for the qualitative and quantitative assessment of the human immune compatibility and immune activity towards biomedical applications. The immune characterization of the tested materials on the basis of intrinsic physical-chemical and immunological properties, through the combination of the most innovative technologies such as single-cell mass cytometry (CyTOF), will open breakthrough perspectives for the development of new therapeutic approaches applying nanomaterials as immunomodulators, scaffolds for tissue engineering, cancer therapy, and antibacterial agents.

MX-MAP will develop key chemistry and immune-based strategies for MXene medical applications. The implication of this project extends beyond the specific nanoscience program greatly advancing the engineering process of 2D materials and their use in biomedicine. The MX-MAP project involves fourteen key players in European and non-European countries, including the United States, Canada, Saudi Arabia, and three partners from Ukraine, coming from academia and SMEs.

This program will provide strong support for the development of the careers of young brilliant scientists who want to grow towards an interdisciplinary vision of Science. Chemistry, biology, immunology, engineering, and cancer research are the expertise of MX-MAP. The senior team members are among the most influential scientists, including Prof. Yury Gogotsi (H-index=168) - inventor of MXenes, Prof. Klaus Ley (H-index=147) - one of the most cited immunologists worldwide, and Prof.

Husam N Alshareef (H-index=99). The Consortium is perfectly balanced in terms of equal gender presence; the project Coordinator Lucia Gemma Delogu is a female, and 2 out 4 of four WP leaders are female. The project embraces a large view of inclusiveness and diversity, including countries with smaller economies such as Ukraine.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di PadovaPadovaItalyCoordinator
Khalifa University of Science and TechnologyAbu DhabiAEAssociatedpartner
The University of ManitobaManitobaCanadaAssociatedpartner
Universitaetsklinikum EssenEssenGermanyParticipant
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinDublinIrelandParticipant
Cambridge Raman Imaging SRLVeronaItalyParticipant
Universita Degli Studi Di SassariSassariItalyParticipant
Latvijas UniversitateRigaLatviaParticipant
Univerzitet U Novom SaduNovi SadSerbiaParticipant
King Abdullah University of Science and TechnologyThuwalSAAssociatedpartner
Ankara UniversitesiTandogan AnkaraTürkiyeParticipant
Materials Research CenterKievUkraineParticipant
Sumy State UniversitySumyUkraineParticipant
Augusta University Research Institute, Inc.AugustaUnited StatesAssociatedpartner
Drexel UniversityPhiladelphiaUnited StatesAssociatedpartner
La Jolla Institute for Allergy and ImmunologyLa Jolla CaUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI